Aminoglycosides were evaluated for in-vitro antiviral activity against Foot and Mouth Disease Virus.
Answers are grounded in this paper and cite their sources.
In-vitro evaluation alone warrants no clinical change in FMDV management; leaves open further antiviral screening in veterinary research.
Since the discovery of penicillin in 1928 many antibiotics including aminoglycosides, blactams, fluoroquinolones, and others have been applied clinically for the treatment of many growing number of multidrug-resistant strains of bacteria. Aminoglycosides in particular are being examined to find new compounds or derivatives that might overcome the existing resistant pathogens and prevent or slow the development of novel resistant pathogens.
No takes yet. Share an insight, caveat, or question.
A 2019 study studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: